Director Omnibus Decision – 24 IPRsJuly 14, 2026
Notice of Decisions on Institution — 2026-07-14
Patent Trial and Appeal Board
Total Proceedings
24
in this notice
Total Denied
14
discretionary + merits
Total Instituted
10
trial granted
Grant Rate
42%
58% denial rate
Trial Instituted· 10 proceedings
PGR2026-00025IPR2026-00235IPR2026-00233IPR2026-00138IPR2026-00228IPR2026-00222IPR2026-00276IPR2026-00137IPR2026-00244IPR2026-00250
Discretionary Denial· 13 proceedings
IPR2026-00284IPR2026-00307IPR2026-00261IPR2026-00308IPR2026-00300IPR2026-00306IPR2026-00281IPR2026-00255IPR2026-00309IPR2026-00305IPR2026-00310IPR2026-00283IPR2026-00282
Institution Denied· 1 proceeding
IPR2026-00245
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases.
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Aug. 25, 2026Aesthetic Management Partners, LLC and Aesthetic Management Partners, Inc. v. HydraFacial LLC